<DOC>
	<DOCNO>NCT00114946</DOCNO>
	<brief_summary>This randomize , open-label , active-control , multicenter trial compare two oxaliplatin/Avastin-based treatment sequence first-line therapy metastatic colorectal cancer . The study design compare efficacy two treatment sequence respect progression free survival ( PFS ) overall survival .</brief_summary>
	<brief_title>A Study Compare Two Avastin-Based Treatment Regimens Treatment Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Signed Informed Consent Form Metastatic locally advance unresectable colorectal cancer Measurable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) Age &gt; = 18 year ECOG performance status 0 1 Adequate hematologic , hepatic , renal function time study entry begin prescribe study therapy , accord institutional guideline Use effective form contraception study ( subject childbearing potential partner ) Prior treatment Avastin Hypersensitivity study drug ingredient Current , recent ( within 4 week first infusion study ) , plan participation experimental drug study Genentechsponsored Avastin cancer study History malignancy ( except squamous basal cell carcinoma skin , carcinoma situ cervix , carcinoma situ colon rectum effectively treat ) unless complete remission therapy malignancy least 5 year Known brain central nervous system metastases Prior treatment advance metastatic colorectal cancer Prior treatment antiangiogenesis agent , either adjuvant metastatic setting Concurrent use investigational antineoplastic agent ( include 4 week prior enrollment ) Medical psychiatric disorder would interfere informed consent compliance , would render subject high risk participation study followup procedure Active infection require antibiotic Day 1 New York Heart Association ( NYHA ) Grade II great CHF Evidence bleed diathesis coagulopathy Grade &gt; 1 peripheral neuropathy ( define NCI CTCAE , v3.0 ) Lack physical integrity upper gastrointestinal tract history malabsorption syndrome Blood pressure &gt; 150/100 mmHg Major surgical procedure , open biopsy , significant traumatic injury within 30 day prior Day 1 ; anticipation need major surgical procedure course study Minor surgical procedure fine needle aspiration core biopsy within 7 day prior Day 1 Urine protein : creatinine ratio &gt; = 1.0 screen History abdominal fistula , gastrointestinal perforation , intraabdominal abscess within 6 month prior Day 1 Serious , nonhealing wound , ulcer , bone fracture History myocardial infarction within 6 month prior Day 1 Unstable angina Clinically significant peripheral vascular disease History stroke within 6 month prior Day 1 Pregnancy ( positive pregnancy test ) lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Metastatic Colorectal Cancer OASIS</keyword>
</DOC>